Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?:
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Erlangen ; Nürnberg
Friedrich-Alexander-Universität Erlangen-Nürnberg
2020
|
| Schlagworte: | |
| Online-Zugang: | Volltext Volltext Volltext |
| Beschreibung: | 1 Online-Ressource |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV047432805 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 210820s2020 gw |||| o||u| ||||||eng d | ||
| 015 | |a 21,O03 |2 dnb | ||
| 016 | 7 | |a 1227041284 |2 DE-101 | |
| 024 | 7 | |a urn:nbn:de:bvb:29-opus4-157700 |2 urn | |
| 035 | |a (OCoLC)1268187970 | ||
| 035 | |a (DE-599)DNB1227041284 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |8 3\p |a eng | |
| 044 | |a gw |c XA-DE-BY | ||
| 049 | |a DE-29 | ||
| 084 | |8 2\p |a 610 |2 23sdnb | ||
| 084 | |8 1\p |a 616.994 |2 23ksdnb | ||
| 100 | 1 | |a Wessely, Anja |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020? |c Anja Wessely, Theresa Steeb, Ulrike Leiter, Claus Garbe, Carola Berking, Markus Vincent Heppt |
| 264 | 1 | |a Erlangen ; Nürnberg |b Friedrich-Alexander-Universität Erlangen-Nürnberg |c 2020 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 583 | 1 | |a Archivierung/Langzeitarchivierung gewährleistet |5 DE-101 |2 pdager | |
| 653 | |a immune checkpoint blockade | ||
| 653 | |a cutaneous squamous cell carcinoma | ||
| 653 | |a skin cancer | ||
| 653 | |a cemiplimab | ||
| 653 | |a pembrolizumab | ||
| 700 | 1 | |a Steeb, Theresa |e Verfasser |4 aut | |
| 700 | 1 | |a Leiter, Ulrike |e Verfasser |4 aut | |
| 700 | 1 | |a Garbe, Claus |e Verfasser |4 aut | |
| 700 | 1 | |a Berking, Carola |e Verfasser |4 aut | |
| 700 | 1 | |a Heppt, Markus Vincent |e Verfasser |4 aut | |
| 787 | 0 | 8 | |i Sonderdruck aus |t International Journal of Molecular Sciences |g Vol. 21 (2020) |o 10.3390/ijms21239300 |
| 856 | 4 | 0 | |u https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-157700 |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://d-nb.info/1227041284/34 |x Langzeitarchivierung Nationalbibliothek |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |q application/pdf |u https://open.fau.de/handle/openfau/15770 |x Verlag |z kostenfrei |3 Volltext |
| 912 | |a ebook | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-032835231 | ||
| 883 | 0 | |8 1\p |a aepkn |c 0,99835 |d 20210213 |q DE-101 |u https://d-nb.info/provenance/plan#aepkn | |
| 883 | 0 | |8 2\p |a aepsg |c 0,99951 |d 20210213 |q DE-101 |u https://d-nb.info/provenance/plan#aepsg | |
| 883 | 1 | |8 3\p |a npi |d 20210212 |q DE-101 |u https://d-nb.info/provenance/plan#npi | |
Datensatz im Suchindex
| _version_ | 1804182719662391296 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Wessely, Anja Steeb, Theresa Leiter, Ulrike Garbe, Claus Berking, Carola Heppt, Markus Vincent |
| author_facet | Wessely, Anja Steeb, Theresa Leiter, Ulrike Garbe, Claus Berking, Carola Heppt, Markus Vincent |
| author_role | aut aut aut aut aut aut |
| author_sort | Wessely, Anja |
| author_variant | a w aw t s ts u l ul c g cg c b cb m v h mv mvh |
| building | Verbundindex |
| bvnumber | BV047432805 |
| collection | ebook |
| ctrlnum | (OCoLC)1268187970 (DE-599)DNB1227041284 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02323nmm a2200541zc 4500</leader><controlfield tag="001">BV047432805</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">210820s2020 gw |||| o||u| ||||||eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">21,O03</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1227041284</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">urn:nbn:de:bvb:29-opus4-157700</subfield><subfield code="2">urn</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1268187970</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1227041284</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BY</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">2\p</subfield><subfield code="a">610</subfield><subfield code="2">23sdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">1\p</subfield><subfield code="a">616.994</subfield><subfield code="2">23ksdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Wessely, Anja</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?</subfield><subfield code="c">Anja Wessely, Theresa Steeb, Ulrike Leiter, Claus Garbe, Carola Berking, Markus Vincent Heppt</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Erlangen ; Nürnberg</subfield><subfield code="b">Friedrich-Alexander-Universität Erlangen-Nürnberg</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="583" ind1="1" ind2=" "><subfield code="a">Archivierung/Langzeitarchivierung gewährleistet</subfield><subfield code="5">DE-101</subfield><subfield code="2">pdager</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune checkpoint blockade</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cutaneous squamous cell carcinoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">skin cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cemiplimab</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pembrolizumab</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Steeb, Theresa</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Leiter, Ulrike</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Garbe, Claus</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Berking, Carola</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Heppt, Markus Vincent</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="787" ind1="0" ind2="8"><subfield code="i">Sonderdruck aus</subfield><subfield code="t">International Journal of Molecular Sciences</subfield><subfield code="g">Vol. 21 (2020)</subfield><subfield code="o">10.3390/ijms21239300</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-157700</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://d-nb.info/1227041284/34</subfield><subfield code="x">Langzeitarchivierung Nationalbibliothek</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="q">application/pdf</subfield><subfield code="u">https://open.fau.de/handle/openfau/15770</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032835231</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">aepkn</subfield><subfield code="c">0,99835</subfield><subfield code="d">20210213</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepkn</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">aepsg</subfield><subfield code="c">0,99951</subfield><subfield code="d">20210213</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepsg</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">npi</subfield><subfield code="d">20210212</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#npi</subfield></datafield></record></collection> |
| id | DE-604.BV047432805 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T17:58:57Z |
| indexdate | 2024-07-10T09:12:01Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032835231 |
| oclc_num | 1268187970 |
| open_access_boolean | 1 |
| owner | DE-29 |
| owner_facet | DE-29 |
| physical | 1 Online-Ressource |
| psigel | ebook |
| publishDate | 2020 |
| publishDateSearch | 2020 |
| publishDateSort | 2020 |
| publisher | Friedrich-Alexander-Universität Erlangen-Nürnberg |
| record_format | marc |
| spelling | Wessely, Anja Verfasser aut Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020? Anja Wessely, Theresa Steeb, Ulrike Leiter, Claus Garbe, Carola Berking, Markus Vincent Heppt Erlangen ; Nürnberg Friedrich-Alexander-Universität Erlangen-Nürnberg 2020 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Archivierung/Langzeitarchivierung gewährleistet DE-101 pdager immune checkpoint blockade cutaneous squamous cell carcinoma skin cancer cemiplimab pembrolizumab Steeb, Theresa Verfasser aut Leiter, Ulrike Verfasser aut Garbe, Claus Verfasser aut Berking, Carola Verfasser aut Heppt, Markus Vincent Verfasser aut Sonderdruck aus International Journal of Molecular Sciences Vol. 21 (2020) 10.3390/ijms21239300 https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-157700 Resolving-System kostenfrei Volltext https://d-nb.info/1227041284/34 Langzeitarchivierung Nationalbibliothek kostenfrei Volltext application/pdf https://open.fau.de/handle/openfau/15770 Verlag kostenfrei Volltext 1\p aepkn 0,99835 20210213 DE-101 https://d-nb.info/provenance/plan#aepkn 2\p aepsg 0,99951 20210213 DE-101 https://d-nb.info/provenance/plan#aepsg 3\p npi 20210212 DE-101 https://d-nb.info/provenance/plan#npi |
| spellingShingle | Wessely, Anja Steeb, Theresa Leiter, Ulrike Garbe, Claus Berking, Carola Heppt, Markus Vincent Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020? |
| title | Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020? |
| title_auth | Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020? |
| title_exact_search | Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020? |
| title_exact_search_txtP | Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020? |
| title_full | Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020? Anja Wessely, Theresa Steeb, Ulrike Leiter, Claus Garbe, Carola Berking, Markus Vincent Heppt |
| title_fullStr | Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020? Anja Wessely, Theresa Steeb, Ulrike Leiter, Claus Garbe, Carola Berking, Markus Vincent Heppt |
| title_full_unstemmed | Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020? Anja Wessely, Theresa Steeb, Ulrike Leiter, Claus Garbe, Carola Berking, Markus Vincent Heppt |
| title_short | Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020? |
| title_sort | immune checkpoint blockade in advanced cutaneous squamous cell carcinoma what do we currently know in 2020 |
| url | https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-157700 https://d-nb.info/1227041284/34 https://open.fau.de/handle/openfau/15770 |
| work_keys_str_mv | AT wesselyanja immunecheckpointblockadeinadvancedcutaneoussquamouscellcarcinomawhatdowecurrentlyknowin2020 AT steebtheresa immunecheckpointblockadeinadvancedcutaneoussquamouscellcarcinomawhatdowecurrentlyknowin2020 AT leiterulrike immunecheckpointblockadeinadvancedcutaneoussquamouscellcarcinomawhatdowecurrentlyknowin2020 AT garbeclaus immunecheckpointblockadeinadvancedcutaneoussquamouscellcarcinomawhatdowecurrentlyknowin2020 AT berkingcarola immunecheckpointblockadeinadvancedcutaneoussquamouscellcarcinomawhatdowecurrentlyknowin2020 AT hepptmarkusvincent immunecheckpointblockadeinadvancedcutaneoussquamouscellcarcinomawhatdowecurrentlyknowin2020 |